ELI-006

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameELI-006
Drug Alias NameN/A
ClassificationVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsEpstein-Barr Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesElicio Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesElicio Therapeutics
Active IndicationsN/A
Inactive IndicationsEpstein-Barr Virus Infections

Other Information

ATC CodeN/A
Related LinksN/A